(marketscreener.com) 28 Sep, 2023 Intercept acquisition by Alfasigma reflects NASH failure, says GlobalData Share Print page Posted in Pharma The acquisition of Intercept Pharmaceuticals by the Italian pharmaceutical company Alfasigma became...https://www.marketscreener.com/quote/stock/GLOBALDATA-PLC-13101755/news/GlobalData-Intercept-acquisition-by-Alfasigma-reflects-NASH-failure-says-GlobalData-44935647/?utm_medium=RSS&utm_content=20230928
Alfasigma is an Italy-based pharmaceutical company that researches and develops novel therapeutics for diseases such as metabolic and digestive disorders.